Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FCL.NS Stock Summary
Top 10 Correlated ETFs
FCL.NS
In the News
FCL.NS Financial details
Company Rating
Buy
Market Cap
39.84B
Income
1.05B
Revenue
5.24B
Book val./share
35.99
Cash/share
4.73
Dividend
0.8
Dividend %
0.22%
Employees
201
Optionable
No
Shortable
Yes
Earnings
31 Oct 2022
P/E
38.62
Forward P/E
-
PEG
4.26
P/S
7.73
P/B
10.17
P/C
77.05
P/FCF
17098.27
Quick Ratio
1.69
Current Ratio
2.27
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
9.48
EPS next Y
-
EPS next Q
-
EPS this Y
60.36%
EPS next Y
-
EPS next 5Y
-71.23%
EPS last 5Y
31.59%
Revenue last 5Y
23.36%
Revenue Q/Q
9.86%
EPS Q/Q
21.98%
-
-
-
-
SMA20
11.07%
SMA50
1.05%
SMA100
12.45%
Inst Own
-
Inst Trans
-
ROA
20%
ROE
56%
ROC
0.33%
Gross Margin
38%
Oper. Margin
25%
Profit Margin
20%
Payout
-
Shs Outstand
110.77M
Shs Float
31.16M
-
-
-
-
Target Price
-
52W Range
203.0-368.25
52W High
-0.96%
52W Low
+79.53%
RSI
75.79
Rel Volume
3.01
Avg Volume
478.8K
Volume
1.44M
Perf Week
11.64%
Perf Month
17.74%
Perf Quarter
15.37%
Perf Half Y
20.1%
-
-
-
-
Beta
0.912
-
-
Volatility
20.86%, 19.79%
Prev Close
0.11%
Price
364.45
Change
-0.15%
FCL.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 16.26 | 17.5 | 19.57 | 33.11 | 46.68 | |
Net income per share | 2.02 | 1.17 | 3.84 | 4.98 | 7.97 | |
Operating cash flow per share | 1.08 | 2.55 | 0.83 | 1.21 | 9.77 | |
Free cash flow per share | 0.37 | 1.98 | -1.35 | -0.82 | 8.01 | |
Cash per share | 1.72 | 2.32 | 2.52 | 2.78 | 5.53 | |
Book value per share | 14.27 | 15.25 | 18.86 | 23.67 | 31.48 | |
Tangible book value per share | 14.23 | 15.26 | 18.92 | 23.77 | 31.56 | |
Share holders equity per share | 14.27 | 15.25 | 18.86 | 23.67 | 31.48 | |
Interest debt per share | 0.23 | 0.28 | 0.33 | 0.21 | 0.73 | |
Market cap | 4.61B | 1.64B | 7.3B | 20.01B | 25.82B | |
Enterprise value | 4.49B | 1.49B | 7.11B | 19.72B | 25.51B | |
P/E ratio | 20.48 | 12.51 | 17.15 | 36.27 | 29.23 | |
Price to sales ratio | 2.55 | 0.84 | 3.36 | 5.46 | 4.99 | |
POCF ratio | 38.39 | 5.77 | 78.86 | 149.62 | 23.86 | |
PFCF ratio | 110.72 | 7.41 | -48.85 | -219.03 | 29.08 | |
P/B Ratio | 2.91 | 0.96 | 3.49 | 7.63 | 7.4 | |
PTB ratio | 2.91 | 0.96 | 3.49 | 7.63 | 7.4 | |
EV to sales | 2.48 | 0.77 | 3.27 | 5.38 | 4.93 | |
Enterprise value over EBITDA | 12.9 | 4.16 | 16.26 | 27.02 | 21.28 | |
EV to operating cash flow | 37.39 | 5.26 | 76.74 | 147.46 | 23.58 | |
EV to free cash flow | 107.84 | 6.76 | -47.53 | -215.87 | 28.74 | |
Earnings yield | 0.05 | 0.08 | 0.06 | 0.03 | 0.03 | |
Free cash flow yield | 0.01 | 0.13 | -0.02 | 0 | 0.03 | |
Debt to equity | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Net debt to EBITDA | -0.35 | -0.4 | -0.45 | -0.4 | -0.25 | |
Current ratio | 3.67 | 3.68 | 3.3 | 3.41 | 3.59 | |
Interest coverage | 89.74 | 255.25 | 224.03 | 249.23 | 132.63 | |
Income quality | 0.36 | 1.29 | 0.17 | 0.18 | 0.94 | |
Dividend Yield | 0.01 | 0.02 | 0 | 0 | 0 | |
Payout ratio | 0.11 | 0.24 | 0.03 | 0.09 | 0.07 | |
Sales general and administrative to revenue | 0.01 | 0.04 | 0.03 | 0.02 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | |
Capex to operating cash flow | -0.65 | -0.22 | -2.61 | -1.68 | -0.18 | |
Capex to revenue | -0.04 | -0.03 | -0.11 | -0.06 | -0.04 | |
Capex to depreciation | -7.83 | -5.36 | -16.41 | -8.96 | -4.54 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 25.49 | 20.08 | 40.36 | 51.51 | 75.16 | |
ROIC | 0.15 | 0.13 | 0.15 | 0.2 | 0.24 | |
Return on tangible assets | 0.12 | 0.06 | 0.16 | 0.17 | 0.21 | |
Graham Net | 4.45 | 5.02 | 6.47 | 7.85 | 9.06 | |
Working capital | 788.25M | 840.73M | 1.14B | 1.64B | 1.62B | |
Tangible asset value | 1.58B | 1.7B | 2.1B | 2.63B | 3.5B | |
Net current asset value | 780.45M | 835.22M | 1.13B | 1.62B | 1.59B | |
Invested capital | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | |
Average receivables | 534.67M | 662.44M | 878.81M | 1.18B | 1.19B | |
Average payables | 158.82M | 221.39M | 301.06M | 478.04M | 530.66M | |
Average inventory | 230.9M | 230.86M | 249.2M | 441.74M | 534.44M | |
Days sales outstanding | 129.22 | 128.21 | 180.39 | 127.87 | 76.68 | |
Days payables outstanding | 64.5 | 68.87 | 95.08 | 90.71 | 50.96 | |
Days of inventory on hand | 77.42 | 62.12 | 74.22 | 91.97 | 50.89 | |
Receivables turnover | 2.82 | 2.85 | 2.02 | 2.85 | 4.76 | |
Payables turnover | 5.66 | 5.3 | 3.84 | 4.02 | 7.16 | |
Inventory turnover | 4.71 | 5.88 | 4.92 | 3.97 | 7.17 | |
ROE | 0.14 | 0.08 | 0.2 | 0.21 | 0.25 | |
Capex per share | -0.71 | -0.56 | -2.18 | -2.03 | -1.75 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.14 | 9.86 | 12.46 | 11.95 | 13.11 | |
Net income per share | 1.86 | 2 | 2.34 | 2.32 | 2.83 | |
Operating cash flow per share | 0 | 0 | 0.02 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0.02 | 0 | 0 | |
Cash per share | 3.64 | 0 | 5.54 | 0 | 4.73 | |
Book value per share | 27.09 | 0 | 31.54 | 0 | 35.99 | |
Tangible book value per share | 27.09 | 0 | 31.62 | 0 | 35.99 | |
Share holders equity per share | 27.09 | 0 | 31.54 | 0 | 35.99 | |
Interest debt per share | 0.04 | 0.02 | 0.59 | 0.02 | 0.18 | |
Market cap | 38.91B | 27.99B | 25.77B | 33.31B | 35.45B | |
Enterprise value | 38.65B | 27.99B | 25.47B | 33.31B | 35.2B | |
P/E ratio | 47.28 | 31.58 | 24.95 | 32.43 | 28.26 | |
Price to sales ratio | 28.97 | 25.62 | 18.71 | 25.19 | 24.4 | |
POCF ratio | 0 | 0 | 10.87K | 0 | 0 | |
PFCF ratio | 0 | 0 | 10.87K | 0 | 0 | |
P/B Ratio | 12.99 | 0 | 7.39 | 0 | 8.89 | |
PTB ratio | 12.99 | 0 | 7.39 | 0 | 8.89 | |
EV to sales | 28.78 | 25.62 | 18.49 | 25.19 | 24.23 | |
Enterprise value over EBITDA | 140.22 | 92.22 | 73.18 | 94.69 | 83.77 | |
EV to operating cash flow | 0 | 0 | 10.74K | 0 | 0 | |
EV to free cash flow | 0 | 0 | 10.74K | 0 | 0 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0.02 | 0 | 0 | |
Debt to assets | 0 | 0 | 0.01 | 0 | 0 | |
Net debt to EBITDA | -0.95 | 0 | -0.87 | 0 | -0.58 | |
Current ratio | 4.71 | 0 | 3.59 | 0 | 2.27 | |
Interest coverage | 116.43 | 145.07 | 130.57 | 160.78 | 153.85 | |
Income quality | 0 | 0 | 0.01 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0 | 0.01 | 0 | 0.01 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 33.67 | 0 | 40.71 | 0 | 47.87 | |
ROIC | 0.07 | 0 | 0.07 | 0 | 0.08 | |
Return on tangible assets | 0.06 | 0 | 0.06 | 0 | 0.06 | |
Graham Net | 9.26 | 0 | 9.08 | 0 | 5.69 | |
Working capital | 1.61B | 401.69M | 1.62B | 604.77M | 1.53B | |
Tangible asset value | 3B | 0 | 3.5B | 0 | 3.99B | |
Net current asset value | 1.58B | 401.69M | 1.59B | 604.77M | 1.49B | |
Invested capital | 0 | 0 | 0.02 | 0 | 0 | |
Average receivables | 566.99M | 566.99M | 543.04M | 543.04M | 755.3M | |
Average payables | 183.06M | 183.06M | 236.79M | 236.79M | 437.84M | |
Average inventory | 227.21M | 227.21M | 236.47M | 236.47M | 212.98M | |
Days sales outstanding | 75.99 | 0 | 70.99 | 0 | 93.59 | |
Days payables outstanding | 35.6 | 0 | 48.54 | 0 | 88.45 | |
Days of inventory on hand | 44.18 | 0 | 48.47 | 0 | 43.03 | |
Receivables turnover | 1.18 | 0 | 1.27 | 0 | 0.96 | |
Payables turnover | 2.53 | 0 | 1.85 | 0 | 1.02 | |
Inventory turnover | 2.04 | 0 | 1.86 | 0 | 2.09 | |
ROE | 0.07 | 0 | 0.07 | 0 | 0.08 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
FCL.NS Frequently Asked Questions
What is Fineotex Chemical Limited stock symbol ?
Fineotex Chemical Limited is a IN stock and trading under the symbol FCL.NS
What is Fineotex Chemical Limited stock quote today ?
Fineotex Chemical Limited stock price is $364.45 today.
Is Fineotex Chemical Limited stock public?
Yes, Fineotex Chemical Limited is a publicly traded company.